208 related articles for article (PubMed ID: 27127165)
1. Initial Report of Phase II Study on Bi-weekly SOX plus Cetuximab Treatment for Wild-type K-RAS Advanced and Recurrent Colorectal Cancer.
Ogawa M; Anan T; Suzuki T; Okuma M; Ichihara K; Hasegawa T; Yoshida K; Yanaga K
Anticancer Res; 2016 May; 36(5):2505-11. PubMed ID: 27127165
[TBL] [
